BSERaaj Medisafe India LtdMediumNeutral
Announced Fri, 29 May · 17:37 IST

The Board of Directors of the Company in its meeting held on May 29, 2026 has inter-alia approved the following: a. Audited Financial Statements and cash Flow Statements for the year ....

Related Party TransactionsResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-9.7%1-day move
₹88.01
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-9.7-14.2-18.4-14.8-14.8-16.5-18.1
Up moveDown movePending
AI summary

The Board of Raaj Medisafe India Ltd met on May 29, 2026 and approved the audited financial statements and cash flow statements for the year ended March 31, 2026. The Board also took on record the Draft Auditors Report for FY 2026. Key approvals included related party transactions entered into by the Company during the period October 1, 2025 to March 31, 2026, and the Integrated (Finance) Report which includes statement of utilization of funds raised through Preferential Allotment. The Board authorized RTA for conversion of physical shares to DEMAT format as per SEBI guidelines. No specific financial numbers or auditor opinions were disclosed in this filing.

Likely market impact

The filing is procedural in nature; approval of related party transactions and preferential allotment fund utilization may be of interest to minority shareholders but no quantitative details were provided. Investors should await the full financial results filing for revenue and profit specifics.